Are twindemics occurring?

The emergence and spread of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes coronavirus disease (COVID‐19), prompted worldwide COVID‐19 surveillance. To investigate the impact of COVID‐19 on influenza activity, we used global surveillance data collected since 2019 to compa...

Full description

Saved in:
Bibliographic Details
Published inInfluenza and other respiratory viruses Vol. 17; no. 1; pp. e13090 - n/a
Main Authors Takashita, Emi, Watanabe, Shinji, Hasegawa, Hideki, Kawaoka, Yoshihiro
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.01.2023
John Wiley and Sons Inc
Subjects
Coronaviruses
COVID-19
COVID-19 - epidemiology
Epidemiology
France
Humans
Influenza
Influenza, Human - epidemiology
Respiratory diseases
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Short Communication
Short Communications
Spain
Surveillance
United States
Viral diseases
viral interference
Viruses
France
United States
Spain
South Korea
United Kingdom > UK
Japan
Europe
Africa
Italy
East Asia
Corsica
Germany
COVID-19
influenza
SARS-CoV-2
viral interference
Online AccessGet full text

Cover

More Information
Summary:The emergence and spread of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes coronavirus disease (COVID‐19), prompted worldwide COVID‐19 surveillance. To investigate the impact of COVID‐19 on influenza activity, we used global surveillance data collected since 2019 to compare the number of cases positive for COVID‐19 and for influenza across 22 representative countries (Australia, Brazil, Canada, China, Egypt, France, Germany, India, Israel, Italy, Japan, Mexico, The Netherlands, The Philippines, Poland, The Republic of Korea, South Africa, Spain, Thailand, The United Kingdom, The United States, and Vietnam). Our results demonstrate alternating prevalence of SARS‐CoV‐2 and influenza virus.
Bibliography:This work was supported by a Grant‐in‐Aid for Emerging and Re‐emerging Infectious Diseases from the Ministry of Health, Labour and Welfare, Japan (21HA2003), by JSPS KAKENHI (JP18K10036), by the Japan Program for Infectious Diseases Research and Infrastructure (JP22wm0125002), and by a grant (JP223fa627001) from the Japan Agency for Medical Research and Development (AMED).
Funding Information
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Funding Information This work was supported by a Grant‐in‐Aid for Emerging and Re‐emerging Infectious Diseases from the Ministry of Health, Labour and Welfare, Japan (21HA2003), by JSPS KAKENHI (JP18K10036), by the Japan Program for Infectious Diseases Research and Infrastructure (JP22wm0125002), and by a grant (JP223fa627001) from the Japan Agency for Medical Research and Development (AMED).
ISSN:1750-2640
1750-2659
DOI:10.1111/irv.13090